FDA Inspection 1281734 — Danny Rischin, MBBS, FRACP, MD

Danny Rischin, MBBS, FRACP, MD — FEI 3038201891

The FDA completed an inspection of Danny Rischin, MBBS, FRACP, MD on Aug 22, 2025 in Melbourne. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 22, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Melbourne (Australia)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.